The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Invega Sustenna/Xeplion/Invega Trinza was produced by Roche.
Results found that 92.5%% of patients treated with Invega Hafyera and 95% treated with Invega Trinza were relapse-free at 12 months. ... The long-acting regime joins Janssen’s existing one-month and three-month formulations, Invega Sustenna and Invega
J&J sells a once-monthly version of paliperidone as Invega Sustenna in the US and Xeplion in Europe, but the reduced dosing frequency could give the franchise a competitive advantage ... Xeplion/Invega Sustenna is already a big earner for J&J, with sales
The FDA has approved Johnson &Johnson's Invega Trinza (three-month paliperidone palmitate) for schizophrenia. ... Invega Sustenna, which is marketed as Xeplion in Europe, saw its 2014 sales grow by 27% to $1.6bn and J&J will be hopig Invega Trinza will
1
Welcome to the Difference Collective – a healthcare communications team of 80+ talented experts who Deliver Differently. We’re purpose-built around...